Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Income from Continuing Operations (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Income from Continuing Operations data on record, last reported at 689000.0 in Q4 2012.

  • For Q4 2012, Income from Continuing Operations rose 70.97% year-over-year to 689000.0; the TTM value through Dec 2012 reached 4496000.0, up 32.82%, while the annual FY2012 figure was 7394000.0, 3.69% up from the prior year.
  • Income from Continuing Operations reached 689000.0 in Q4 2012 per SNOA's latest filing, up from 842000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 689000.0 in Q4 2012 and bottomed at 2404000.0 in Q2 2010.
  • Average Income from Continuing Operations over 3 years is 1580454.55, with a median of 1727000.0 recorded in 2010.
  • The widest YoY moves for Income from Continuing Operations: up 70.97% in 2012, down 47.5% in 2012.
  • A 3-year view of Income from Continuing Operations shows it stood at 2066000.0 in 2010, then dropped by 14.86% to 2373000.0 in 2011, then soared by 70.97% to 689000.0 in 2012.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 689000.0 in Q4 2012, 842000.0 in Q3 2012, and 782000.0 in Q2 2012.